Abstracts

The Eighth JCA-AACR Special Joint Conference invites you to submit your presentation to be shared at the Poster Sessions taking place between June 28(Fri.)-30(Sun.), 2024 in Kyoto, Japan.
For instructions on how to submit your presentation, please see the submission guidelines.

Submission Guidelines

  • The abstract submission deadline is on May 12(Sun.),(JST) CLOSED
    (Please note that the deadline has been extended)
  • Those who wish to submit their abstracts are requested to complete their registration and payment prior to the deadline above.
  • The abstract submission link will be sent to you via an auto-generated receipt once your payment has been completed with a credit card.
  • The number of abstract submissions as a Lead presenter is limited to 1 (one) submission per author. However, this does not limit the number of submission as co-authors of abstracts.
  • All submissions shall be peer-reviewed.
  • The Organizing Committee reserves the right to make the final decision on all submissions.
  • Notification of submission acceptance will be made to individual authors by May 20 (Mon.), 2024.
  • Accepted abstracts must be presented in Kyoto by the  pre-registered author.
  • All authors (including responsible researchers) are required to submit the COI (Japanese Cancer Association/Conflict of Interest (COI) disclosure).
  • The abstracts will be published as conference proceedings on-site and in a downloadable electronic version, in exactly the same format as they were submitted.

Categories

  1. AI, computational biology
  2. Bioimaging
  3. Cancer genomic medicine
  4. Cancer model systems
  5. Cancer prevention
  6. Clinical trials
  7. Diagnostics
  8. Drug resistance
  9. Epidemiology
  10. Epigenetics and epigenomics
  11. Evolution and heterogeneity
  12. Genetics and genomics
  13. Hereditary cancer and germline predisposition
  14. Immunology and immunotherapy
  15. Inflammation and cancer
  16. Liquid biopsy
  17. Metastasis and recurrence
  18. Microbiome
  19. Novel therapeutic targets
  20. Omics analysis
  21. Real-world evidence and real-world data
  22. Scientific significance of robotic surgery
  23. Simulation
  24. Single cell analysis
  25. Somatic mutations in precancerous tissue and tumor initiation
  26. Spatial transcriptome analysis
  27. Splicing variant and epitranscriptome
  28. Tumor microenvironment
  29. Others

Instructions for Poster Presentation

>>COI Policy

copyright © 2024 JCA-AACR Special Joint Conference